Sato, E.; Nakayama, K.; Razia, S.; Nakamura, K.; Ishikawa, M.; Minamoto, T.; Ishibashi, T.; Yamashita, H.; Iida, K.; Kyo, S.
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. Int. J. Mol. Sci. 2018, 19, 1710.
https://doi.org/10.3390/ijms19061710
AMA Style
Sato E, Nakayama K, Razia S, Nakamura K, Ishikawa M, Minamoto T, Ishibashi T, Yamashita H, Iida K, Kyo S.
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. International Journal of Molecular Sciences. 2018; 19(6):1710.
https://doi.org/10.3390/ijms19061710
Chicago/Turabian Style
Sato, Emi, Kentaro Nakayama, Sultana Razia, Kohei Nakamura, Masako Ishikawa, Toshiko Minamoto, Tomoka Ishibashi, Hitomi Yamashita, Kouji Iida, and Satoru Kyo.
2018. "ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma" International Journal of Molecular Sciences 19, no. 6: 1710.
https://doi.org/10.3390/ijms19061710
APA Style
Sato, E., Nakayama, K., Razia, S., Nakamura, K., Ishikawa, M., Minamoto, T., Ishibashi, T., Yamashita, H., Iida, K., & Kyo, S.
(2018). ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. International Journal of Molecular Sciences, 19(6), 1710.
https://doi.org/10.3390/ijms19061710